Covidien plc · Dublin 2 Ireland (NYSE: COV)
Key Covidien plc Financials
| Company Type | Public -(NYSE: COV) Headquarters |
|---|---|
| Fiscal Year-End | September |
| 2011 Sales (mil.) | $11,574.0 |
| 2011 Employees | 41,300 |
Covidien plc Stock Quote (NYSE: COV)
| Latest 02/15/12 12:43:37 EST | Change ($) | Change (%) | High | Low |
|---|---|---|---|---|
| $52.26 | $52.56 | $52.04 |
Quotes delayed 15 minutes for NASDAQ, 20 minues for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions. |
Covidien plc Income Statement
| Sep 11 | Sep 10 | Sep 09 | |
| Revenue | 11,574.0 | 10,429.0 | 10,677.0 |
| Cost of Goods Sold | 4,996.0 | 4,624.0 | 4,938.0 |
| Gross Profit | 6,578.0 | 5,805.0 | 5,739.0 |
| Gross Profit Margin | 56.8% | 55.7% | 53.8% |
| SG&A Expense | 3,538.0 | 3,219.0 | 3,086.0 |
| Depreciation & Amortization | 599.0 | 489.0 | 440.0 |
| Operating Income | 2,375.0 | 2,063.0 | 1,856.0 |
| Operating Margin | 20.5% | 19.8% | 17.4% |
| Nonoperating Income | 22.0 | 40.0 | 145.0 |
| Nonoperating Expenses | (181.0) | (177.0) | (150.0) |
| Income Before Taxes | 2,216.0 | 1,926.0 | 1,851.0 |
| Income Taxes | 333.0 | 363.0 | 949.0 |
| Net Income After Taxes | 1,883.0 | 1,563.0 | 902.0 |
| Continuing Operations | 1,883.0 | 1,563.0 | 902.0 |
| Discontinued Operations | (15.0) | 69.0 | 5.0 |
| Total Operations | 1,868.0 | 1,632.0 | 907.0 |
| Total Net Income | 1,868.0 | 1,632.0 | 907.0 |
| Net Profit Margin | 16.1% | 15.6% | 8.5% |
| Diluted EPS from Total Net Income | 3.76 | 3.24 | 1.79 |
| Dividends per Share | 0.60 | 0.74 | 0.66 |
All amounts in millions of US Dollars except per share amounts.
Covidien plc Balance Sheet
| Assets | Sep 11 | Sep 10 | Sep 09 |
| Current Assets | |||
| Cash | 1,503.0 | 1,565.0 | 1,467.0 |
| Net Receivables | 1,748.0 | 1,708.0 | 1,880.0 |
| Inventories | 1,513.0 | 1,381.0 | 1,334.0 |
| Other Current Assets | 1,009.0 | 1,086.0 | 781.0 |
| Total Current Assets | 5,773.0 | 5,740.0 | 5,462.0 |
| Net Fixed Assets | 2,705.0 | 2,608.0 | 2,661.0 |
| Other Noncurrent Assets | 11,896.0 | 12,039.0 | 9,016.0 |
| Total Assets | 20,374.0 | 20,387.0 | 17,139.0 |
| Liabilities | Sep 11 | Sep 10 | Sep 09 |
| Current Liabilities | |||
| Accounts Payable | 576.0 | 586.0 | 500.0 |
| Short-Term Debt | 11.0 | 255.0 | 30.0 |
| Other Current Liabilities | 1,813.0 | 2,285.0 | 1,709.0 |
| Total Current Liabilities | 2,400.0 | 3,126.0 | 2,239.0 |
| Long-Term Debt | 4,197.0 | 4,451.0 | 2,961.0 |
| Other Noncurrent Liabilities | 3,960.0 | 3,836.0 | 3,938.0 |
| Total Liabilities | 10,557.0 | 11,413.0 | 9,138.0 |
| Shareholder's Equity | |||
| Preferred Stock Equity | 0.0 | -- | 0.0 |
| Common Stock Equity | 9,817.0 | 8,974.0 | 8,001.0 |
| Total Equity | 9,817.0 | 8,974.0 | 8,001.0 |
| Shares Outstanding (thou.) | 481,958.0 | 495,081.0 | 499,049.7 |
All amounts in millions of US Dollars except per share amounts.
Covidien plc Cash Flow Statement
| Sep 11 | Sep 10 | Sep 09 | |
| Net Operating Cash Flow | 2,182 | 2,231 | 1,875 |
| Net Investing Cash Flow | (480.0) | (3,206.0) | (1,027.0) |
| Net Financing Cash Flow | (1,771.0) | 1,060.0 | (575.0) |
| Net Change in Cash | (62.0) | 98.0 | 259.0 |
| Depreciation & Amortization | 599.0 | 489.0 | 440.0 |
| Capital Expenditures | (473.0) | (471.0) | (468.0) |
| Cash Dividends Paid | (396.0) | (360.0) | (322.0) |
All amounts in millions of US Dollars except per share amounts.


